Scienza e Tecnologia
Pharmacogenomics Market To Cross $10,505.3 Million Value by 2030, says P&S Intelligence
Diagnostic facilities are expected to grow at the highest pharmacogenomics market CAGR in the coming years. Diagnostic centers account for the majority of these items in use, owing to the considerable research, which has resulted in highly complex tests and systems. Furthermore, technological improvements have transformed the services offered by diagnostic centers, thus resulting in higher patient traffic.
Direct-to-consumer (DTC) tests are in vitro diagnostic (IVD) tests that are sold directly to consumers without the involvement of healthcare practitioners. The user is often asked to take a specimen (saliva, urine, or other) and send it straight to the corporation for analysis and testing. The number of people who may now obtain genetic information on themselves is growing because of DTC testing, which offers opportunities to market players.
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Prajneesh Kumar
P&S Intelligence
Phone: +1-347-960-6455
enquiry@psmarketresearch.com
https://www.psmarketresearch.com
LinkedInTwitter
Logo: https://mma.prnewswire.com/media/1224988/P_and_S_Intelligence_Logo.jpg